Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks

Page 5 of 12

8. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Number of Hedge Fund Holders In Q3 2024: 62

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a New York-based biotechnology company that develops medicines for eye diseases, dermatitis, asthma, and other ailments. One of the firm’s most important products is its treatment for age-related macular degeneration. The drug is called Eyelea, and it is key to Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)’s hypothesis as was evident in October last year when the shares dropped by 9% after a higher dose variant of the drug missed analyst sales estimates. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)’s shares are down by 3.4% year-to-date, and here’s what Cramer said about the stock:

“I’ll be doing Regeneron, which is another stock that seems to have disappointed people. Bizarre.”

Page 5 of 12